Radiotherapy volume delineation using dynamic [18F]-FDG PET/CT imaging in patients with oropharyngeal cancer: a pilot study

被引:0
作者
Antti Silvoniemi
Mueez U Din
Sami Suilamo
Tony Shepherd
Heikki Minn
机构
[1] Turku University Hospital,Department of Otorhinolaryngology – Head and Neck Surgery
[2] University of Turku,Turku PET Centre
[3] Turku University Hospital,Department of Oncology and Radiotherapy
[4] Turku University Hospital,Department of Medical Physics
来源
International Journal of Computer Assisted Radiology and Surgery | 2016年 / 11卷
关键词
Oropharyngeal cancer; PET/CT; [; F]-FDG; Dynamic PET/CT imaging; Contouring; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2059 / 2069
页数:10
相关论文
共 180 条
  • [1] Marur S(2014)Oropharyngeal squamous cell carcinoma treatment: current standards and future directions Curr Opin Oncol 26 252-258
  • [2] Burtness B(2011)Prevalence and impact of complications on outcomes in patients hospitalized for oral and oropharyngeal cancer treatment Oral Surg Oral Med Oral Pathol Oral Radiol Endod 5 581-591
  • [3] Lee MK(2007)Concurrent chemoradiation for locally advanced oropharyngeal cancer Am J Otolaryngol 28 3-8
  • [4] Nalliah RP(2009)Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer Int J Radiat Oncol Biol Phys 73 759-763
  • [5] Kim MK(2010)Impact of PET/CT on planning of radiotherapy in head and neck cancer Q J Nucl Med Mol Imaging 54 521-532
  • [6] Elangovan S(2006)Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer Int J Cancer 119 2620-2623
  • [7] Allareddy V(2010)The role of human papillomavirus in the increased incidence of base of tongue cancer Int J Cancer 126 2879-2884
  • [8] Kumar-Gajendrareddy P(2011)Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 4294-4301
  • [9] Allareddy V(2010)Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 24-35
  • [10] Nguyen NP(2014)Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review) Int J Oncol 44 1799-1805